Newsroom
Pangaea Oncology investigators prove liquid biopsy can be used for clinical lung cancer diagnostics
Pangaea Oncology featured in Business section of La Vanguardia
Pangaea Oncology reinforces its leadership in liquid biopsy in Europe through the ELBA project
More Articles...
- Pangaea Oncology among the finalists competing for Best Listed European company in expansion
- CDTI funds Pangaea Oncology project on liquid biopsy & multiplex analyses for cancer diagnostics
- Pangaea Oncology selected as one of 15 companies with greatest trading volume for inclusion in new Ibex index
- Javier Rivela interviewed on Estratégias de Inversión